Home/Filings/4/0001562180-24-006017
4//SEC Filing

PAKOLA STEVE 4

Accession 0001562180-24-006017

CIK 0001590877other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 6:41 PM ET

Size

5.2 KB

Accession

0001562180-24-006017

Insider Transaction Report

Form 4
Period: 2024-08-01
PAKOLA STEVE
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2024-08-01+58,386165,578 total
Footnotes (1)
  • [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of February 1, 2025, August 1, 2025, February 1, 2026 and August 1, 2026 while the recipient provides continuous service to the Issuer.

Issuer

REGENXBIO Inc.

CIK 0001590877

Entity typeother

Related Parties

1
  • filerCIK 0001700659

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 6:41 PM ET
Size
5.2 KB